U.S. Physical Therapy's declining ROCE trend is concerning. Despite reinvestment, returns are shrinking and shareholder returns have been flat over five years. The stock doesn't show multi-bagger traits, suggesting investors may find better options elsewhere.
Investors remain optimistic about U.S. Physical Therapy's robust earnings outlook. The market's high P/E ratio reflects strong future growth expectations for the company, despite the industry average.
The cautious investor sentiment towards the company's future is reflected in declining share price and EPS. A potential stabilization is indicated by a 0.7% TSR gain over past year, albeit below market return.
美国理疗保健股票讨论区
2023Q1营收增长12.8%,营业利润增长16.2%,净利润继续受利息费用和其它费用增长影响而下滑了4.6%。
目前价格117.2,市盈率52,市盈率TTM升到了54.3,估值缺乏吸引力。
暂无评论